{"nct_id":"NCT02282020","title":"Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments","status":"COMPLETED","status_verified_date":"2022-07","start_date":"2015-02-06","start_date_type":"ACTUAL","primary_completion_date":"2018-10-10","primary_completion_date_type":"ACTUAL","completion_date":"2022-07-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AZN"]}